| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | RAB9B |
| Uniprot No | Q9NP90 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-201 aa |
| 活性数据 | MSGKSLLLKV ILLGDGGVGK SSLMNRYVTN KFDSQAFHTI GVEFLNRDLE VDGRFVTLQI WDTAGQERFK SLRTPFYRGA DCCLLTFSVD DRQSFENLGN WQKEFIYYAD VKDPEHFPFV VLGNKVDKED RQVTTEEAQT WCMENGDYPY LETSAKDDTN VTVAFEEAVR QVLAVEEQLE HCMLGHTIDL NSGSKAGSSC C |
| 分子量 | 22.7 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于重组人RAB9B蛋白的3篇参考文献及其摘要内容，涵盖功能研究和疾病相关性方向：
1. **文献名称**：*"RAB9B modulates vesicular transport in the Golgi-endosomal pathway"*
**作者**：Smith A, et al. (2018)
**摘要**：研究通过CRISPR/Cas9敲除RAB9B基因，发现其调控晚期内体到高尔基体的逆向运输，重组人RAB9B蛋白过表达可部分恢复囊泡运输缺陷，并解析其与效应蛋白TIP47的相互作用机制。
2. **文献名称**：*"RAB9B mutations impair viral assembly in HIV-1 infection"*
**作者**：Li Y, et al. (2020)
**摘要**：利用重组RAB9B蛋白进行功能补偿实验，揭示其通过促进宿主细胞ESCRT复合体招募，调控HIV病毒颗粒的释放。突变体RAB9B-Q56L显著抑制病毒出芽，提示其作为抗病毒治疗靶点的潜力。
3. **文献名称**：*"Structural basis of RAB9B activation by its guanine nucleotide exchange factor"*
**作者**：Gupta R, et al. (2021)
**摘要**：通过X射线晶体学解析重组人RAB9B蛋白与其鸟苷酸交换因子复合物的三维结构，发现GEF诱导的构象变化促使GTP结合，为设计靶向RAB9B信号通路的小分子抑制剂奠定结构基础。
**备注**：以上文献为示例性内容，实际文献信息需通过PubMed/Google Scholar检索获取。若需具体论文链接或扩展至4篇，可补充RAB9B在肿瘤转移(如*Nature Cell Biology*, 2022)或罕见病中的研究。
**Background of Recombinant Human RAB9B Protein**
RAB9B, a member of the RAB GTPase family, plays critical roles in intracellular membrane trafficking and vesicular transport. As a small GTP-binding protein, it cycles between active GTP-bound and inactive GDP-bound states, regulating vesicle formation, movement, and fusion. RAB9B is specifically involved in retrograde transport from endosomes to the *trans*-Golgi network (TGN), lysosomal biogenesis, and secretion pathways. It also interacts with effector proteins like TIP47 and the HOPS complex to mediate cargo sorting and membrane tethering.
Distinct from its paralog RAB9A, RAB9B exhibits broader tissue expression and may have unique roles in immune cells and neuronal functions. Dysregulation of RAB9B is linked to pathologies, including cancer metastasis, viral infection (e.g., hepatitis C virus trafficking), and neurodegenerative disorders. Recombinant RAB9B protein, typically produced in *E. coli* or mammalian expression systems, retains GTPase activity and serves as a tool for studying vesicular transport mechanisms, drug discovery, and exploring therapeutic strategies targeting membrane trafficking disorders. Its structural domains, including conserved GTP-binding motifs, make it a focus for functional and biochemical studies in cellular logistics.
×
